Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers
Clinical trial NCT01585636 · COMPLETED
Trial details
- NCT number
- NCT01585636
- Sponsor
- Sequella, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-02-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.